ILSI-Biomed Israel

The new BioInform Magazine – a platform to connect

Two young Israeli scientists - Tal Shprung (M.Sc. in Biochemistry from the faculty of medicine, Tel-Aviv University) and  Alon Rayhman (M.Sc. from the Hebrew University, the faculty of agriculture) have come up with a unique idea for the biotech community in Israel: BioInform - a bio oriented magazine, that is aimed solely to the biotech community in Israel (pharmaceutical companies, medical device industry, biological facilities, academia institutions, ministerial offices and more). ...

Early Initiation of Treatment with Copaxone Provides Greater Effects in Delaying Conversion to Clinically Definite MS

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone® (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study. Early treatment with Copaxone reduce...

May 23-25, 2011: save the date for ILSI-BioMed Israel!

Yes. It is about time to open your calendars and write down the next date: May 23-25 2011. ILSI-BioMed Israel 2011, that is. The 10th international Life Science & Technology Week is just around the corner. Time do flies... The event follows the highly successful 2010 BioMed conference which attracted more than 6000 participants from 51 countries. What an event! ILSI-BioMed 2011 will present high-quality program, featuring top-notch industry executives. Israel's most innovative medi...

Introducing: the 1st ever Virtual Bio-Med

So you missed this one... You were on vacation, your aunt dropped by for a visit. You missed it. No worry! For a one time fee, you can now view nearly 100 of ILSI-BioMed 2010's most important sessions. Following a short registration on site, sessions will be available for an unlimited amount of time - on one computer. Viewers in Israel: http://biomedisrael.newtonstrand.com/ All other viewers: http://biomed.newtonstrand.com/

Successful Strategies for Medical Device Market Clearance

Getting your product to market as quickly as possible means your company management must navigate its way down the regulatory path wisely and efficiently. Recent changes in the regulatory environment in the U.S. and Europe can make this a challenging and confusing process. Dr. Maria Donawa, Presdient, Roger Gray, Vice President, Quality and Regulatory, and Tami Abudi, Senior Associate, Clinical Affairs, will be presenting this half-day seminar in Israel on October 18 to help your company ...